Literature DB >> 14673267

Topical imiquimod therapy for cutaneous T-cell lymphoma.

Jennifer H Do1, Susan S McLaughlin, Anthony A Gaspari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14673267     DOI： 10.1111/j.1540-9740.2003.02258.x

Source DB:  PubMed          Journal:  Skinmed        ISSN： 1540-9740


× No keyword cloud information.
  2 in total

1.  Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma.

Authors:  Alain H Rook; Joel M Gelfand; Joel C Gelfand; Maria Wysocka; Andrea B Troxel; Bernice Benoit; Christian Surber; Rosalie Elenitsas; Marie A Buchanan; Deborah S Leahy; Rei Watanabe; Ilan R Kirsch; Ellen J Kim; Rachael A Clark
Journal:  Blood       Date:  2015-07-30       Impact factor: 22.113

Review 2.  Therapeutic advances in cutaneous T-cell lymphoma.

Authors:  Oleg E Akilov; Larisa Geskin
Journal:  Skin Therapy Lett       Date:  2011-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.